Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C

Background: An increase in the incidence of hepatocellular carcinoma (HCC) in Japan since the 1980s suggests an imminent outbreak in other countries where viral spread occurred more recently. Interferon therapy for chronic hepatitis C, in general, has been shown to prevent HCC. Aims: To determine th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yoshida, H, Tateishi, R, Arakawa, Y, Sata, M, Fujiyama, S, Nishiguchi, S, Ishibashi, H, Yamada, G, Yokosuka, O, Shiratori, Y, Omata, M
Format:	Artigo
Language:	Inglês
Published:	BMJ Group 2004
Subjects:	Liver
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1773993/ https://ncbi.nlm.nih.gov/pubmed/14960528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.030353
Tags:	Add Tag No Tags, Be the first to tag this record!

Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C

Similar Items